The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbvie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Forest Laboratories (Inst); GE Healthcare (Inst); Gilead Sciences (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sunovion (Inst); Teva (Inst); UCB (Inst); Ultragenyx Pharmaceuticals (Inst); Vertex (Inst)
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Forest Laboratories (Inst); GE Healthcare (Inst); Gilead Sciences (Inst); Janssen (Inst); Novartis (Inst); Pfizer (Inst); Sunovion (Inst); Teva (Inst); UCB (Inst); Ultragenyx Pharmaceuticals (Inst); Vertex (Inst)
Comparative effectiveness of everolimus versus endocrine monotherapies among post-menopausal women with HR+/HER2- metastatic breast cancer: A retrospective chart review of community oncology practices in the US.
 
Jipan Xie
Consulting or Advisory Role - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Ethicon (Inst); Forest Laboratories (Inst); Genentech (Inst); Melinta Therapeutics (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Shire (Inst)
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Ethicon (Inst); Forest Laboratories (Inst); Genentech (Inst); Melinta Therapeutics (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Shire (Inst)
 
Yanni Hao
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Nanxin Li
Consulting or Advisory Role - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forest Laboratories (Inst); Novartis (Inst); Sanofi (Inst)
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Forest Laboratories (Inst); Novartis (Inst); Sanofi (Inst)
 
Peggy L. Lin
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Lifescan Pharma (Inst); Novartis (Inst); Shire (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Lifescan Pharma (Inst); Novartis (Inst); Shire (Inst); Takeda (Inst)
 
Erika Ohashi
Consulting or Advisory Role - Abbvie (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cempra (Inst); Forest Laboratories (Inst); GE Healthcare (Inst); Janssen Biotech (Inst); Novartis (Inst); Purdue Pharma (Inst); Shire (Inst); Takeda (Inst); Teva (Inst)
Research Funding - Abbvie (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cempra (Inst); Forest Laboratories (Inst); GE Healthcare (Inst); Janssen (Inst); Novartis (Inst); Purdue Pharma (Inst); Shire (Inst); Takeda (Inst); Teva (Inst)
 
Valerie Koo
Consulting or Advisory Role - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Millennium (Inst); Novartis (Inst); Shire (Inst); Teva (Inst)
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Millennium (Inst); Novartis (Inst); Shire (Inst); Teva (Inst)
 
James E. Signorovitch
No Relationships to Disclose
 
Eric Qiong Wu
Consulting or Advisory Role - Abbvie (Inst); Alcon (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Ethicon (Inst); Forest Laboratories (Inst); Genentech (Inst); Melinta Therapeutics (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Shire (Inst); Vertex (Inst)
Research Funding - Abbvie (Inst); Alcon (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Ethicon (Inst); Forest Laboratories (Inst); Genentech (Inst); Melinta Therapeutics (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Shire (Inst); Vertex (Inst)